For Aetna commercial plans, prior authorization typically requires a letter of medical necessity from the prescribing provider documenting the patient's BMI, at least one comorbidity, participation in a structured diet and exercise program for a minimum of three months, and the clinical rationale for the requested medication
Tirzepatide, without glucagon agonism, does not carry that specific signal
Wegovy is an injectable medication taken under the skin in the stomach area (abdomen), upper leg (thigh), or upper arm and per the instructions of a healthcare provider
Brand positioning, competitive dynamics, and perceived clinical benefit determine pricing far more than production expenses
Tirzepatide reduces the risk of cardiovascular diseases in patients with diabetes